SEATTLE, March 17 /PRNewswire-FirstCall/ -- Craig Philips, President of Cell Therapeutics, Inc. (CTI) will present at the 8th Annual WBBA Invest Northwest Conference on Wednesday, March 18th at 10:10 AM in the Harbor Dining Room of the Bell Harbor Conference Center.
Philips was named President of CTI in August of 2008. Prior to CTI, Philips was Vice President and General Manager of Bayer Healthcare Oncology, with direct responsibilities for all Development and Commercial Operations. Starting in 2006 Philips led Bayer’s U.S. oncology operations, following the integration of the U.S. oncology businesses from Berlex and Bayer. He oversaw the U.S. oncology operations, with sales of $350 million and a staff of over 150. Prior to Bayer, Philips was the head of Berlex Oncology as Vice President and General Manager at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering Plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, cardiology, and CNS.
The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at http://www.celltherapeutics.com.
CONTACT: Media, Dan Eramian, +1-206-272-4343, cell, +1-206-854-1200,
media@ctiseattle.com; or Investors, Ed Bell, +1-206-282-7100, or Lindsey
Jesch Logan, +1-206-272-4347, fax, +1-206-272-4434, invest@ctiseattle.com,
all of Cell Therapeutics, Inc.
Web site: http://www.celltherapeutics.com/
